| ID | Description | GeneID | Count |
| hsa04933 | AGE-RAGE signaling pathway in diabetic complications | MMP2, TNF, BCL2, RELA, AKT1, VEGFA, MAPK1, IL6, STAT1, F3, ICAM1, IL1B, CCL2, SELE, VCAM1, CXCL8, PRKCB, NOS3, THBD, SERPINE1, COL1A1, COL3A1, STAT3, EDN1, MAPK8 | 25 |
| hsa05418 | Fluid shear stress and atherosclerosis | MMP2, MMP9, TNF, BCL2, KDR, RELA, AKT1, VEGFA, TP53, HMOX1, CAV1, ICAM1, IL1B, CCL2, SELE, VCAM1, NOS3, PLAT, THBD, IFNG, GSTP1, NFE2L2, NQO1, GSTM1, EDN1, IKBKB, MAPK8 | 27 |
| hsa05417 | Lipid and atherosclerosis | RXRA, PPARG, MMP9, TNF, BCL2, CASP9, MMP3, RELA, AKT1, MAPK1, IL6, TP53, MMP1, CYP1A1, ICAM1, IL1B, CCL2, SELE, VCAM1, CXCL8, NOS3, NFE2L2, CD40LG, GSK3B, STAT3, OLR1, IKBKB, MAPK8, APOB | 29 |
| hsa04066 | HIF-1 Signaling pathway | NOS2, BCL2, RELA, EGFR, AKT1, VEGFA, MAPK1, EGF, IL6, HIF1A, ERBB2, HMOX1, PRKCB, NOS3, SERPINE1, IFNG, INSR, HK2, STAT3, EDN1, TIMP1 | 21 |
| hsa04657 | IL-17 Signaling pathway | PTGS2, MMP9, TNF, IL4, MMP3, RELA, MAPK1, IL6, MMP1, IL1B, CCL2, CXCL8, IFNG, CXCL10, GSK3B, IKBKB, MAPK8 | 17 |
| hsa04668 | TNF Signaling pathway | PTGS2, MMP9, TNF, MMP3, RELA, AKT1, MAPK1, IL6, ICAM1, IL1B, CCL2, SELE, VCAM1, CXCL10, EDN1, IKBKB, MAPK8, CREB1 | 18 |
| hsa05215 | Prostate cancer | AR, MMP9, BCL2, CASP9, MMP3, RELA, EGFR, AKT1, MAPK1, EGF, TP53, ERBB2, PLAT, GSTP1, GSK3B, IKBKB, CREB1 | 17 |
| hsa05207 | Chemical carcinogenesis-receptor activation | ESR1, AR, RXRA, ADRB2, CYP3A4, CYP1A2, PGR, ADRB1, BCL2, RELA, EGFR, AKT1, VEGFA, MAPK1, EGF, CYP1A1, PRKCB, BIRC5, PPARA, GSTM1, STAT3, CREB1 | 22 |
| hsa05142 | Chagas disease | NOS2, TNF, RELA, AKT1, MAPK1, IL10, IL6, IL1B, CCL2, CXCL8, IL2, SERPINE1, IFNG, IKBKB, MAPK8 | 15 |
| hsa04931 | Insulin resistance | TNF, RELA, AKT1, IL6, PRKCB, NOS3, SLC2A4, INSR, PPARA, GSK3B, STAT3, IKBKB, MAPK8, SREBF1, CREB1 | 15 |
| hsa05212 | Pancreatic cancer | CASP9, RELA, EGFR, AKT1, VEGFA, MAPK1, EGF, TP53, STAT1, ERBB2, STAT3, IKBKB, MAPK8 | 13 |
| hsa05161 | Hepatitis B | MMP9, TNF, BCL2, CASP9, RELA, AKT1, MAPK1, IL6, TP53, STAT1, CXCL8, PRKCB, BIRC5, STAT3, IKBKB, MAPK8, CREB1 | 17 |
| hsa05144 | Malaria | TNF, IL10, IL6, ICAM1, IL1B, CCL2, SELE, VCAM1, CXCL8, IFNG, CD40LG | 11 |
| hsa04151 | PI3K-Akt signaling pathway | RXRA, IL4, BCL2, CASP9, KDR, RELA, EGFR, AKT1, VEGFA, MAPK1, EGF, IL6, TP53, ERBB2, NOS3, IL2, COL1A1, INSR, SPP1, IGF2, GSK3B, IKBKB, CREB1 | 23 |
| hsa05219 | Bladder cancer | MMP2, MMP9, EGFR, VEGFA, MAPK1, EGF, TP53, MMP1, ERBB2, CXCL8 | 10 |
| hsa04926 | Relaxin signaling pathway | NOS2, MMP2, MMP9, RELA, EGFR, AKT1, VEGFA, MAPK1, MMP1, NOS3, COL1A1, COL3A1, EDN1, MAPK8, CREB1 | 15 |
| hsa05160 | Hepatitis C | RXRA, TNF, CASP9, RELA, EGFR, AKT1, MAPK1, EGF, TP53, STAT1, IFNG, PPARA, CXCL10, GSK3B, STAT3, IKBKB | 16 |
| hsa05145 | Toxoplasmosis | NOS2, TNF, BCL2, CASP9, RELA, AKT1, MAPK1, IL10, STAT1, IFNG, CD40LG, STAT3, IKBKB, MAPK8 | 14 |
| hsa01521 | EGFR tyrosine kinase inhibitor resistance | BCL2, KDR, EGFR, AKT1, VEGFA, MAPK1, EGF, IL6, ERBB2, PRKCB, GSK3B, STAT3 | 12 |
| hsa05167 | Kaposi sarcoma-associated herpesvirus infection | PTGS2, CASP9, RELA, AKT1, VEGFA, MAPK1, IL6, TP53, HIF1A, STAT1, ICAM1, CXCL8, GSK3B, STAT3, IKBKB, MAPK8, CREB1 | 17 |
|
|